摘要
神经母细胞瘤(NB)好发于5岁以下婴幼儿,遗传学异常和临床表型存在高度异质性。即使通过强烈联合化疗、造血干细胞移植、诱导分化和免疫治疗等综合性治疗策略,相当部分转移性NB的预后仍很不理想。深入研究NB转移相关机制,对于靶向干预相关环节,提高NB疗效和预后具有重要临床现实意义。本文介绍转移性NB的流行病学现状和预后,总结NB进展和转移相关研究领域的近期研究进展。
Neuroblastoma(NB)is primarily prevalent in infants and young children under 5 years,and is highly hetergeneous both in terms of genetic aberrations and clinical phenotypes.Even with multi-modality treatment including intensive combination chemotherapy,hematopoietic stem cell transplantation,differentiation induction and immunotherapy,the prognosis of metastatic NB in a great majority of patients is still far from optimal.Therefore,a better understanding of the mechanisms underlying NB metastasis is of great clinical importance as regard to fomulation of novel interventional strategies,and further improvement of therapeutic efficacy and clinical outcomes.In the present review,recent research advances related to NB progression and metastasis are summarized.
作者
谢明芸
何国倩
郭霞
高举
Xie Mingyun;He Guoqian;Guo Xia;Gao Ju(Department of Pediatric Hematology and Oncology,West China Secondu University Hospital.Sichuan University,Key Laboratory of Birth Defects and Related Diseases of Women and Children,Sichuan University,Ministry of Education,Chengdu 610041,China)
出处
《中华转移性肿瘤杂志》
2021年第4期323-326,共4页
Chinese Journal of Metastatic Cancer
基金
四川省科技厅重点研发项目(2020YFS0253)
成都市科技局重点研发支撑计划(2019-YF05-01140-SN)
关键词
神经母细胞瘤
转移机制
研究进展
neuroblastoma
metastasis
mechanism
Research progress